HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Plasma Cell Myeloma

Plasma Cell Myeloma

Plasma cell myeloma, also known as multiple myeloma, is a type of cancer that affects plasma cells in the bone marrow. These abnormal plasma cells multiply uncontrollably, crowding out healthy blood cells and weakening bones. Recent research in cancer therapy has shown promising developments in treating plasma cell myeloma. Immunotherapies, such as CAR-T cell therapy, are being investigated to target and destroy cancerous plasma cells more effectively. Additionally, advancements in precision medicine allow for personalized treatment approaches based on a patient's genetic makeup and disease characteristics. Researchers are also exploring novel drug combinations and targeted therapies to improve outcomes and reduce the side effects of treatment. These innovations offer hope for better management and ultimately, a cure for plasma cell myeloma.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp